Cargando…

Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts

Human epididymal secretory protein E4 (HE4, also known as WAP four-disulphide core domain protein 2) is a new promising biomarker for ovarian cancer but its specificity against ovarian endometriotic cysts is only superficially known. We, thus, analysed serum HE4 concentrations together with a tumour...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huhtinen, K, Suvitie, P, Hiissa, J, Junnila, J, Huvila, J, Kujari, H, Setälä, M, Härkki, P, Jalkanen, J, Fraser, J, Mäkinen, J, Auranen, A, Poutanen, M, Perheentupa, A
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2009
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2676558/ https://www.ncbi.nlm.nih.gov/pubmed/19337252 http://dx.doi.org/10.1038/sj.bjc.6605011

Ejemplares similares

Usefulness of serum HE4 in endometriotic cysts
por: Montagnana, M, et al.
Publicado: (2009)

CT Imaging Findings of Ruptured Ovarian Endometriotic Cysts: Emphasis on the Differential Diagnosis with Ruptured Ovarian Functional Cysts
por: Lee, Young Rae
Publicado: (2011)

Rupture of ovarian endometriotic cyst complicated with endometriosis: A case report
por: Wang, Lu, et al.
Publicado: (2021)

HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm
por: Van Gorp, T, et al.
Publicado: (2011)

Comparison of Serum Anti-Mullerian Hormone-Level Changes in Single-Port Laparoscopic Endometriotic and Non-Endometriotic Ovarian Cyst Enucleations
por: Cabiscuelas, Charmaine A., et al.
Publicado: (2021)

The Endometriotic Tumor Microenvironment in Ovarian Cancer
por: Wendel, Jillian R. Hufgard, et al.
Publicado: (2018)

A relational database to identify differentially expressed genes in the endometrium and endometriosis lesions
por: Gabriel, Michael, et al.
Publicado: (2020)

Management of a Nulliparous IVF Patient with a Declined Ovarian Reserve After Discovery of an Atypical Ovarian Endometriotic Cyst
por: Ke, Xue, et al.
Publicado: (2023)

Gene expression profiling of primary cultures of ovarian epithelial cells identifies novel molecular classifiers of ovarian cancer
por: Le Page, C, et al.
Publicado: (2006)

Cancer incidence in the first-degree relatives of ovarian cancer patients.
por: Auranen, A., et al.
Publicado: (1996)

Primary ovarian leiomyoma associated with endometriotic cyst presenting with symptoms of acute appendicitis: a case report
por: Tomas, Davor, et al.
Publicado: (2009)

Poorly differentiated mucinous carcinoma with signet ring cells in an ovarian endometriotic cyst: a case report
por: Jiao, Yurong, et al.
Publicado: (2019)

Ascitic complement system in ovarian cancer
por: Bjørge, L, et al.
Publicado: (2005)

Comparison of anti-mullerian hormone level in non-endometriotic benign ovarian cyst before and after laparoscopic cystectomy
por: Amooee, Sedigheh, et al.
Publicado: (2015)

Pelvic Artificial Isolation with Ultrasound-Guided Fluid: A New Technique In Ovarian Endometriotic Cyst Transabdominal Sclerotherapy
por: Meng, Bin, et al.
Publicado: (2022)

Circulating biomarkers for detection of ovarian cancer and predicting cancer outcomes
por: Shapira, I, et al.
Publicado: (2014)

Androgen-related expression of G-proteins in ovarian cancer
por: Sheach, L A, et al.
Publicado: (2009)

The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer
por: Popple, A, et al.
Publicado: (2012)

The Optimal Time of Ovarian Reserve Recovery After Laparoscopic Unilateral Ovarian Non-Endometriotic Cystectomy
por: Li, Huaping, et al.
Publicado: (2021)

ASPM and microcephalin expression in epithelial ovarian cancer correlates with tumour grade and survival
por: Brüning-Richardson, A, et al.
Publicado: (2011)

Whole blood-derived miRNA profiles as potential new tools for ovarian cancer screening
por: Häusler, S F M, et al.
Publicado: (2010)

Role of lymphangiogenesis in epithelial ovarian cancer
por: Sundar, S S, et al.
Publicado: (2006)

Factors influencing p53 expression in ovarian cancer as a biomarker of clinical outcome in multicentre studies
por: de Graeff, P, et al.
Publicado: (2006)

Heparan sulphate synthetic and editing enzymes in ovarian cancer
por: Backen, A C, et al.
Publicado: (2007)

A distinct molecular profile associated with mucinous epithelial ovarian cancer
por: Heinzelmann-Schwarz, V A, et al.
Publicado: (2006)

Granulocyte colony-stimulating factor receptor signalling via Janus kinase 2/signal transducer and activator of transcription 3 in ovarian cancer
por: Kumar, J, et al.
Publicado: (2014)

Mammaglobin B (SCGB2A1) is a novel tumour antigen highly differentially expressed in all major histological types of ovarian cancer: implications for ovarian cancer immunotherapy
por: Bellone, S, et al.
Publicado: (2013)

Effect of combined contraceptive pill on immune cell of ovarian endometriotic tissue
por: Waiyaput, Wanwisa, et al.
Publicado: (2021)

Reduced expression of chemokine (C-C motif) ligand-2 (CCL2) in ovarian adenocarcinoma
por: Arnold, J M, et al.
Publicado: (2005)

The ErbB signalling pathway: protein expression and prognostic value in epithelial ovarian cancer
por: de Graeff, P, et al.
Publicado: (2008)

Glycovariant-based lateral flow immunoassay to detect ovarian cancer–associated serum CA125
por: Bayoumy, Sherif, et al.
Publicado: (2020)

Identification of genes and pathways associated with cytotoxic T lymphocyte infiltration of serous ovarian cancer
por: Leffers, N, et al.
Publicado: (2010)

Bidirectional modulation of endogenous EpCAM expression to unravel its function in ovarian cancer
por: van der Gun, B T F, et al.
Publicado: (2013)

Dysregulation of miR-106a and miR-591 confers paclitaxel resistance to ovarian cancer
por: Huh, J H, et al.
Publicado: (2013)

The presence of living endometrial cells in ovarian endometriotic cyst fluid may contribute to the recurrence of endometriosis after surgical excision of endometriomas
por: Xu, Xinxin, et al.
Publicado: (2022)

The VEGF pathway and the AKT/mTOR/p70S6K1 signalling pathway in human epithelial ovarian cancer
por: Trinh, X B, et al.
Publicado: (2009)

Prognostic role of CIP2A expression in serous ovarian cancer
por: Böckelman, C, et al.
Publicado: (2011)

Increased chromosomal stability in cultures of ovarian tumours of low malignant potential compared to cystadenomas
por: Yu, J, et al.
Publicado: (2007)

Modest effect of p53, EGFR and HER-2/neu on prognosis in epithelial ovarian cancer: a meta-analysis
por: de Graeff, P, et al.
Publicado: (2009)

BMI-1 Expression Heterogeneity in Endometriosis-Related and Non-Endometriotic Ovarian Carcinoma
por: Lozneanu, Ludmila, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n01ukdlnc2ghdjv8373qluht4b